Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATO + ATRA vs AIDA in Non-High-Risk APL
NCT00482833Phase 3Completed
- Sponsor
- GIMEMA
- Start
- Aug 2007
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by GIMEMA. Started Aug 2007; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00482833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482833.